Banque Pictet & Cie Sa Biogen Inc. Transaction History

Banque Pictet & Cie Sa

$14.9 Billion
Q4 2024

A detailed history of Banque Pictet & Cie Sa transactions in Biogen Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 63,494 shares of BIIB stock, worth $9.17 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

63,494

Previous 30,735 106.59%

Holding current value

$9.17 Million

Previous $5.96 Million 62.98%

% of portfolio

0.07%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$146.47 - $191.55 $4.8 Million - $6.27 Million	32,759 Added 106.59%	63,494 $9.71 Million
Q3 2024 Oct 21, 2024	BUY	$189.07 - $236.8 $182,641 - $228,748	966 Added 3.24%	30,735 $5.96 Million
Q2 2024 Jul 25, 2024	BUY	$190.52 - $236.72 $377,801 - $469,415	1,983 Added 7.14%	29,769 $6.9 Million
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $412,802 - $521,231	1,947 Added 7.54%	27,786 $5.99 Million
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $404,446 - $486,846	1,817 Added 7.56%	25,839 $6.69 Million
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $3.89 Million - $4.39 Million	-15,354 Reduced 38.99%	24,022 $6.17 Million
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $1.67 Million - $1.93 Million	-6,058 Reduced 13.33%	39,376 $11.2 Million
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $2.2 Million - $2.5 Million	-8,562 Reduced 15.86%	45,434 $12.6 Million
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $2.23 Million - $2.71 Million	8,821 Added 19.53%	53,996 $0
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $1.35 Million - $1.86 Million	6,924 Added 18.1%	45,175 $12.1 Billion
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $4.01 Million - $4.77 Million	-21,388 Reduced 35.86%	38,251 $7.8 Million
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $3.38 Million - $4.26 Million	-17,442 Reduced 22.63%	59,639 $12.6 Million
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $12.3 Million - $15.8 Million	54,819 Added 246.24%	77,081 $18.5 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $2.08 Million - $2.71 Million	7,338 Added 49.17%	22,262 $6.3 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $127,428 - $204,037	-492 Reduced 3.19%	14,924 $5.17 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $174,438 - $204,364	-718 Reduced 4.45%	15,416 $4.31 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $57,411 - $86,418	243 Added 1.53%	16,134 $3.95 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $72,811 - $84,070	-275 Reduced 1.7%	15,891 $4.51 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $909,707 - $1.2 Million	-3,517 Reduced 17.87%	16,166 $4.33 Million
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $1.25 Million - $1.59 Million	-4,651 Reduced 19.11%	19,683 $6.23 Million
Q4 2019 Feb 03, 2020	SELL	$220.06 - $304.07 $1.47 Million - $2.04 Million	-6,694 Reduced 21.57%	24,334 $7.22 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $202,219 - $226,808	-930 Reduced 2.91%	31,028 $7.22 Million
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $407,002 - $448,632	1,856 Added 6.17%	31,958 $7.47 Million
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $1.6 Million - $2.51 Million	7,392 Added 32.55%	30,102 $7.12 Million
Q4 2018 Jan 31, 2019	BUY	$278.5 - $352.75 $211,660 - $268,090	760 Added 3.46%	22,710 $6.83 Million
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $880 - $1,151	3 Added 0.01%	21,950 $7.76 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $30,387 - $36,215	118 Added 0.54%	21,947 $6.37 Million
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $27,995 - $31,356	-91 Reduced 0.42%	21,829 $6.95 Million
Q3 2017 Nov 07, 2017	SELL	$281.15 - $329.69 $567,923 - $665,973	-2,020 Reduced 8.44%	21,920 $6.86 Million
Q2 2017 Aug 09, 2017	BUY	N/A	23,940	23,940 $6.5 Million

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Biogen Inc. Transaction History